- Report of Foreign Issuer (6-K)
November 09 2012 - 4:38PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
______________
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of November 2012
Commission File Number: 001-34541
CHINA CORD BLOOD CORPORATION
|
(Translation of registrant’s name into English)
|
48
th
Floor,
Bank of China Tower
|
1 Garden Road
|
Central
|
Hong Kong S.A.R.
|
(Address of Principal Executive Offices)
|
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F.
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
¨
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
¨
Indicate by check mark whether the registrant
by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule
12g3-2(b) under the Securities Exchange Act of 1934.
If “Yes” is marked, indicate
below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-_______________.
This report and each of the exhibits
to this report are hereby incorporated by reference into the registration statements on Form F-3 (No. 333-168873 and No. 333-183143)
of the Company.
Other Events
Attached hereto as Exhibit
99.1 is a Notice of Annual General Meeting of Shareholders and Proxy Statement and Form of Proxy of China Cord Blood Corporation
(the “Company”) relating to the Company’s 2012 Annual General Meeting.
Where to Find Additional Information
The Company is a foreign
private issuer. As such, the proxy statement is not subject to review and comment by the Securities and Exchange Commission (the
“SEC”).
Shareholders are urged
to carefully read the proxy statement, because it contains important information about the Company and the 2012 Annual General
Meeting of Shareholders. Copies of the proxy statement and other documents filed or submitted by the Company will be available
at the website maintained by the SEC at www.sec.gov. Shareholders may obtain a copy of such filings and the Company’s annual
report, free of charge, from the Company’s website at www.chinacordbloodcorp.com, by contacting our Investor Relations Department
at: ir@chinacordbloodcorp.com or by writing to us at 48
th
Floor, Bank of China Tower, 1 Garden Road, Central, Hong
Kong S.A.R., ATTN: Secretary.
Participants in the Solicitation
The Company and its directors
and executive officers may be deemed to be participants in the solicitation of proxies from the shareholders of the Company in
connection with the 2012 Annual General Meeting of Shareholders. Information regarding certain directors and executive officers
of the Company is available in the Company’s documents filed with or submitted to the SEC. Other information regarding the
participants in the proxy solicitation and descriptions of their direct and indirect interests, by security holdings or otherwise,
are set forth in the proxy statement filed herewith.
Exhibits
|
Exhibit No.
|
|
Description
|
|
99.1
|
|
Notice of Annual General Meeting of Shareholders, Final Proxy Statement and Form of Proxy
|
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
CHINA CORD BLOOD CORPORATION
|
|
|
|
|
|
By:
|
/s/ Albert Chen
|
|
|
Name:
|
Albert Chen
|
|
|
Title:
|
Chief Financial Officer
|
|
Dated: November 9, 2012
Global Cord Blood (NYSE:CO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Global Cord Blood (NYSE:CO)
Historical Stock Chart
From Jul 2023 to Jul 2024